As of April 16, 2025, Vera Therapeutics (VERA) has a market cap of $1.38 billion USD. According to our data, Vera Therapeutics is ranked No.4564 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.38 B |
-48.59%
|
Dec 31, 2024 | $2.68 B |
174.97%
|
Dec 29, 2023 | $0.97 B |
-20.52%
|
Dec 30, 2022 | $1.23 B |
-27.58%
|
Dec 31, 2021 | $1.69 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Aurinia Pharmaceuticals
AUPH
|
$1.06 B |
0.000 M
|
![]() Canada
|
![]() Omeros Corporation
OMER
|
$0.40 B |
-0.000 M
|
![]() USA
|
![]() Calliditas Therapeutics
CALT
|
$1.10 B |
0.000 M
|
![]() Sweden
|
![]() Akebia Therapeutics
AKBA
|
$0.49 B |
-0.000 M
|
![]() USA
|
![]() Travere Therapeutics
TVTX
|
$1.32 B |
-0.000 M
|
![]() USA
|
![]() Rigel Pharmaceuticals
RIGL
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Cara Therapeutics
CARA
|
$24.33 M |
0.000 M
|
![]() USA
|
![]() FibroGen
FGEN
|
$29.89 M |
0.000 M
|
![]() USA
|
![]() Protalix BioTherapeutics
PLX
|
$0.20 B |
0.000 M
|
![]() Israel
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Kiniksa Pharmaceuticals
KNSA
|
$1.54 B |
0.650 B
|
|
![]() Apellis Pharmaceuticals
APLS
|
$2.38 B |
-0.000 M
|
![]() USA
|
Market Cap | = | VERA Stock Price | * | VERA Shares Outstanding |
= | $21.59 | * | 63.77 M | |
= | $1.38 B |